hnRNPLL: A new pancreatic ductal adenocarcinoma therapeutic target

被引：0
|
作者：
Ping, Changyun
机构：
[1] Henan Prov Peoples Hosp, Dept Pathol, Zhengzhou, Peoples R China
[2] Zhengzhou Univ, Peoples Hosp, Zhengzhou, Peoples R China
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2023年 / 38卷
关键词：
hnRNPLL; pancreatic ductal adenocarcinoma (PDAC); therapeutic target;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
0701
引用
收藏
页码：111 / 111
页数：1
相关论文
共 50 条
  • [1] hnRNPLL: A new pancreatic ductal adenocarcinoma therapeutic target
    Ping, Changyun
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 111 - 111
  • [2] New therapeutic Target Structures for Pancreatic ductal Adenocarcinoma Patients?
    Hofmann-Assmus, Marion
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2019, 57 (09): : 1029 - 1029
  • [3] Tumor Stroma as a Therapeutic Target for Pancreatic Ductal Adenocarcinoma
    Lee, Dae Ui
    Han, Beom Seok
    Jung, Kyung Hee
    Hong, Soon-Sun
    BIOMOLECULES & THERAPEUTICS, 2024, 32 (03) : 281 - 290
  • [4] Schlafen 5 as a novel therapeutic target in pancreatic ductal adenocarcinoma
    Fischietti, Mariafausta
    Eckerdt, Frank
    Blyth, Gavin T.
    Arslan, Ahmet D.
    Mati, William M.
    Oku, Chidera, V
    Perez, Ricardo E.
    Lee-Chang, Catalina
    Kosciuczuk, Ewa M.
    Saleiro, Diana
    Beauchamp, Elspeth M.
    Lesniak, Maciej S.
    Verzella, Daniela
    Sun, Leyu
    Fish, Eleanor N.
    Yang, Guang-Yu
    Qiang, Wenan
    Platanias, Leonidas C.
    ONCOGENE, 2021, 40 (18) : 3273 - 3286
  • [5] TRAILshort is a Novel Potential Therapeutic Target in Pancreatic Ductal Adenocarcinoma
    Khandakar, Binny
    Chandrasekar, Aswath P.
    Krogman, Ashton
    VanTreeck, Benjamin
    Cummins, Nathan
    Natesampillai, Sekar
    Garcia-Rivera, Enrique
    Rathore, Mahendra
    Khazaie, Khashayarsha
    Badley, Andrew
    Graham, Rondell
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 1049 - 1049
  • [6] TRAILshort is a Novel Potential Therapeutic Target in Pancreatic Ductal Adenocarcinoma
    Khandakar, Binny
    Chandrasekar, Aswath P.
    Krogman, Ashton
    VanTreeck, Benjamin
    Cummins, Nathan
    Natesampillai, Sekar
    Garcia-Rivera, Enrique
    Rathore, Mahendra
    Khazaie, Khashayarsha
    Badley, Andrew
    Graham, Rondell
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 1049 - 1049
  • [7] Schlafen 5 as a novel therapeutic target in pancreatic ductal adenocarcinoma
    Mariafausta Fischietti
    Frank Eckerdt
    Gavin T. Blyth
    Ahmet D. Arslan
    William M. Mati
    Chidera V. Oku
    Ricardo E. Perez
    Catalina Lee-Chang
    Ewa M. Kosciuczuk
    Diana Saleiro
    Elspeth M. Beauchamp
    Maciej S. Lesniak
    Daniela Verzella
    Leyu Sun
    Eleanor N. Fish
    Guang-Yu Yang
    Wenan Qiang
    Leonidas C. Platanias
    Oncogene, 2021, 40 : 3273 - 3286
  • [8] New Diagnostic and Therapeutic Aspects of Pancreatic Ductal Adenocarcinoma
    Mangge, Harald
    Niedrist, Tobias
    Renner, Wilfried
    Lyer, Stefan
    Alexiou, Christoph
    Haybaeck, Johannes
    CURRENT MEDICINAL CHEMISTRY, 2017, 24 (28) : 3012 - 3024
  • [9] Claudin 18.2 is a potential therapeutic target for zolbetuximab in pancreatic ductal adenocarcinoma
    Xi Wang
    Cheng-Sheng Zhang
    Xu-Yuan Dong
    Yuan Hu
    Bao-Jun Duan
    Jun Bai
    Yin-Ying Wu
    Lin Fan
    Xin-Hua Liao
    Ye Kang
    Peng Zhang
    Meng-Yang Li
    Jiao Xu
    Zhi-Jun Mao
    Hui-Tong Liu
    Xiao-Long Zhang
    Li-Fei Tian
    En-Xiao Li
    World Journal of Gastrointestinal Oncology, 2022, 14 (07) : 1252 - 1264
  • [10] Claudin 18.2 is a potential therapeutic target for zolbetuximab in pancreatic ductal adenocarcinoma
    Wang, Xi
    Zhang, Cheng-Sheng
    Dong, Xu-Yuan
    Hu, Yuan
    Duan, Bao-Jun
    Bai, Jun
    Wu, Yin-Ying
    Fan, Lin
    Liao, Xin-Hua
    Kang, Ye
    Zhang, Peng
    Li, Meng-Yang
    Xu, Jiao
    Mao, Zhi-Jun
    Liu, Hui-Tong
    Zhang, Xiao-Long
    Tian, Li-Fei
    Li, En-Xiao
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, 14 (07) : 1252 - 1264
12345